PlainPharmaWatch

CMS Open Payments · Program Year 2024

Roche Diabetes Care, Inc.

Roche Diabetes Care, Inc. reported $505,278.07 in payments to 18 physicians and teaching hospitals across 60 transactions.

See the rankings → How this is sourced
$505.3K
Total payments
60
Transactions
18
Recipients
+$2.9K
General Payments vs PY2023

Roche Diabetes Care, Inc. reported $505,278.07 in payments to 18 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #760 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $28.1K per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Roche Diabetes Care, Inc. pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#760
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
2
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Roche Diabetes Care, Inc.'s CMS-reported General Payments increased by $2.9K (+46.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ROCHE DIABETES CARE, INC.PY2023: ROCHE DIABETES CARE, INC.PY2024: ROCHE DIABETES CARE, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$6.2KPY2024$9.1K
PY2023
$6,202.39
PY2024
$9,064.34

How Roche Diabetes Care, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Roche Diabetes Care, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$505,278 Top 39% higher than 61% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Roche Diabetes Care, Inc.

$505,278.07: that is what Roche Diabetes Care, Inc. reported in payments to 18 physicians and teaching hospitals during Program Year 2024, spread across 60 transactions ($8.4K per transaction, $28.1K per recipient). The company sits at rank #760 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $8.7K, accounting for 1.7% of the company's reported total and 15 transactions.

General Payment Breakdown by Type

Across 2 types of general payments, Roche Diabetes Care, Inc.'s largest category was "Consulting Fee" at $8.7K - 1.7% of the company's reported total.

How Roche Diabetes Care, Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$8.7K2. Food and Beverage$404.34
Payment Type Amount Transactions
Consulting Fee $8.7K 15
Food and Beverage $404.34 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $3,885.00 (42.9%) of $9,064.34 in this company's General Payments records across 18 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Roche Diabetes Care, Inc.

The five named recipients with the highest reported General Payments from this company

Yevgeniy Kantor$777.00Melissa Katz$777.00Alina Gouller$777.00Chithranjan Nath$777.00Alan Dresner$777.00
  1. 1

    Yevgeniy Kantor

    $777.00 across 1 reported transactions

  2. 2

    Melissa Katz

    $777.00 across 1 reported transactions

  3. 3

    Alina Gouller

    $777.00 across 1 reported transactions

  4. 4

    Chithranjan Nath

    $777.00 across 1 reported transactions

  5. 5

    Alan Dresner

    $777.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $8.4K. Average per recipient: $28.1K.

Total Amount

$505,278.07

Avg per Transaction

$8.4K

Avg per Recipient

$28.1K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Roche Diabetes Care, Inc. Share

0.0%

#760 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Roche Diabetes Care, Inc.

Epimed International, Inc

$506.9K 33 recipients

Central Indiana URS Consumables, LLC

$507.6K 14 recipients

International Rehabilitative Sciences, Inc

$502.5K 1,661 recipients

Insight Medical Systems, Inc.

$500.6K 237 recipients

Thea Pharma Inc.

$512.0K 3,562 recipients

Novartis Pharma AG

$513.5K 73 recipients

Frequently Asked Questions

How much did Roche Diabetes Care, Inc. pay to physicians and hospitals in 2024? ▾
Roche Diabetes Care, Inc. made $505,278.07 in payments to physicians and hospitals in Program Year 2024, across 60 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Roche Diabetes Care, Inc.? ▾
18 physicians and teaching hospitals received payments from Roche Diabetes Care, Inc. in 2024, averaging $28.1K per recipient.
What types of payments did Roche Diabetes Care, Inc. make? ▾
General payments from Roche Diabetes Care, Inc. span 2 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $8.7K, representing 1.7% of the company's reported total.
How does Roche Diabetes Care, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Roche Diabetes Care, Inc. sits at #760 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Roche Diabetes Care, Inc.? ▾
In 2024, Roche Diabetes Care, Inc. averaged $8.4K per transaction across 60 transactions to 18 recipients.
Where does the payment data for Roche Diabetes Care, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Roche Diabetes Care, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.